← Back to Search
Recent Advances In Small Molecule Drug Delivery.
Argaw Kidane, P. Bhatt
Published 2005 · Biology, Medicine
Download PDFAnalyze on Scholarcy
The majority of new drugs, and new drug products, being developed and marketed by the pharmaceutical industry are small molecules. Oral administration remains the most common route of delivering such drugs, typically in the form of immediate-release tablets or capsules. While the immediate-release dosage forms dominate the market today, more specialized and rationalized products incorporating the concepts of drug delivery are being developed to overcome the physicochemical, physiological and pharmacological challenges inherent with the drugs, and to improve the treatment regimens for the patients. Today, these specialized concepts are increasingly being applied to first-generation products and not just products intended for the life cycle management of the franchise.
This paper references
Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro.
L. F. Siew (2004)
Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.
R. Herrero-Vanrell (2005)
Cell targeting by a generic receptor-targeted polymer nanocontainer platform.
P. Brož (2005)
Polymeric nanohybrids for targeting tumor angiogenesis
A. Mitra (2004)
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
C. Olbrich (2004)
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
Cristina Fonseca (2002)
In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery.
S. Al-Saidan (2005)
Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
B. Kang (2004)
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
H. Yamamoto (2005)
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting.
D. Nauman (2001)
pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Jundong Dai (2004)
Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine.
M. Kurkuri (2004)
Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
Y. Chen (2004)
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery.
N. Peppas (2004)
A Novel pH- and Time-Dependent System for Colonic Drug Delivery
Meiling Qi (2003)
Pharmaceutical approaches to colon targeted drug delivery systems.
M. Chourasia (2003)
Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
Y. Zambito (2005)
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Y. Wu (2004)
Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
T. Tanaka (2004)
In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
V. Sinha (2005)
Coating polymers for colon specific drug delivery: a comparative in vitro evaluation.
V. Sinha (2003)
Controlled drug release from hydrogel nanoparticle networks.
G. Huang (2004)
Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles.
Fariyal Ahmed (2004)
Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
T. Goto (2004)
In vivo evaluation of a novel pH‐ and time‐based multiunit colonic drug delivery system
C. Bott (2004)
Folate receptor targeted biodegradable polymeric doxorubicin micelles.
H. Yoo (2004)
Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide.
T. Ouchi (2004)
The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine.
B. Devarakonda (2004)
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates.
H. Yoo (2000)
Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases
S. Feng (2003)
Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines.
P. Arbós (2004)
Colonic drug delivery of 5-fluorouracil: an in vitro evaluation.
V. Sinha (2004)
Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
N. Ubrich (2004)
A PEGylated dendritic nanoparticulate carrier of fluorouracil.
D. Bhadra (2003)
村山 智洋 (2003)
Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
G. Rai (2005)
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
In-vitro and In-vivo Evaluation of Mesalazine–Guar Gum Matrix Tablets for Colonic Drug Delivery
F. Tuğcu-Demiröz (2004)
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
L. Zhang (2004)
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
J. Kipp (2004)
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
K. Tabatt (2004)
Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.
L. Ould-Ouali (2005)
Molecularly designed water soluble, intelligent, nanosize polymeric carriers.
E. Pişkin (2004)
Small molecule toxins targeting tumor receptors.
M. Dyba (2004)
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
Smart Materials: Applications of Nanotechnology in Drug Delivery and Drug Targeting
R. Löbenberg (2003)
Starch acetate microparticles for drug delivery into retinal pigment epithelium-in vitro study.
L. Tuovinen (2004)
Development of Enteric-coated Pectin-based Matrix Tablets for Colonic Delivery of Theophylline
P. Mura (2003)
This paper is referenced by
APPLICATIONS OF FUNGI
S. Nagendar (2010)
Coated colloidosomes as novel drug delivery carriers
Qian Sun (2019)
Silver-Coated Colloidosomes as Carriers for an Anticancer Drug.
Q. Sun (2017)
Identification and Characterization of Novel Anti-phage Compounds using a High Throughput Approach
Zhuang Duan (2016)
Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model
Rajkamal Mittal (2013)
Polymer Stabilized Nanosuspensions Formed via Flash Nanoprecipitation: Nanoparticle Formation, Formulation, and Stability
Pharmaceutical technology management – profitable business avenue
Shivanand P Puthli (2010)
Functional Silver-Coated Colloidosomes as Targeted Carriers for Small Molecules.
Q. Sun (2017)
Starch-Based Hydrogels: Present Status and Applications
H. Ismail (2013)
Preparation and characterization of an anti-inflammatory agent based on a zinc-layered hydroxide-salicylate nanohybrid and its effect on viability of Vero-3 cells
Munirah Ramli (2013)
Chitosan–chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine
V. E. Santo (2012)
In situ forming hydrogels for intra-articular delivery of celecoxib: from polymer design to in vivo studies
A. Petit (2014)
Rapidly reversible hydrophobization: an approach to high first-pass drug extraction.
Sean D. Monahan (2007)
Chitosan-based hydrogels for controlled, localized drug delivery.
N. Bhattarai (2010)
Calvarial Defect Healing Induced by Small Molecule Smoothened Agonist.
Soonchul Lee (2016)
Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides.
M. Trikeriotis (2007)
A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering
X. Li (2012)
Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy
Mallesh Kurakula (2015)
Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres
M. Momoh (2014)
Développement de Polymères à Empreintes Moléculaires pour la Libération Controlée de la Ribavirine et de l'Adénosine -5'-monosphosphate
M. Ayari (2018)
High-relaxivity and luminescent silica nanoparticles as multimodal agents for molecular imaging.
Estelle Lipani (2013)
Intracellularly Biodegradable Polyelectrolyte/Silica Composite Microcapsules as Carriers for Small Molecules.
H. Gao (2016)
Electrostatic surface modifications to improve gene delivery
Ron B. Shmueli (2010)
Swellable and rigid matrices: controlled release matrices with cellulose ethers
P. Colombo (2008)
The anticancer potential of CITme, a quinoline derivative
S. Martins (2011)
A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing
He Liu (2018)
Guiding principles in the design of ligand-targeted nanomedicines.
Bingbing Wang (2014)
Formulation and evaluation of an implantable polymeric configuration for application in AIDS Dementia Complex
Sheri-lee Harilall (2011)
UfasomesMediated Cutaneous Delivery of Dexamethasone: �ormulation and Evaluation of Anti-In�ammatory Activity �y Carrageenin-Induced Rat Paw EdemaModel
Rajkamal Mittal (2015)
Potential use of a megamolecular polysaccharide sacran as a hydrogel-based sustained release system.
K. Motoyama (2014)
Cryomilling for the fabrication of doxorubicin-containing silica-nanoparticle/polycaprolactone nanocomposite films.
Y. Gao (2016)
Oral insulin delivery using pH-responsive hydrogel and gold nanoparticle hybrid carrier
C. Leung (2010)See more